ESMO mini oral data presented. mOS in PD>1% now 35.5 months (previously reported 25 months), in the PD >50% category mOS not reached! (previously 38 months reported, maybe expect +50 months if i understood the table correctly).
Data highly promising, looking kickass against a ph3 comparison arm against Ipi+Nivo+chemo.
Has Eftilagimod shown enough potential to warrant a commercialisation deal?
- Forums
- ASX - By Stock
- Overnight Market report
ESMO mini oral data presented. mOS in PD>1% now 35.5 months...
-
- There are more pages in this discussion • 540 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
43.5¢ |
Change
0.015(3.57%) |
Mkt cap ! $619.6M |
Open | High | Low | Value | Volume |
41.5¢ | 44.0¢ | 41.5¢ | $1.416M | 3.301M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 38735 | 42.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.5¢ | 41215 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32856 | 0.425 |
2 | 36804 | 0.420 |
1 | 24000 | 0.415 |
3 | 199312 | 0.410 |
3 | 127700 | 0.405 |
Price($) | Vol. | No. |
---|---|---|
0.435 | 41215 | 1 |
0.440 | 190452 | 9 |
0.445 | 46340 | 4 |
0.450 | 181569 | 13 |
0.455 | 747 | 1 |
Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |